Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 1
2005 2
2007 2
2008 2
2009 2
2010 3
2011 3
2012 8
2013 3
2014 3
2015 6
2016 5
2017 2
2018 9
2019 8
2020 1
2021 7
2022 2
2023 5
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Results by year

Filters applied: . Clear all
Page 1
Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial.
Mehanna H, Robinson M, Hartley A, Kong A, Foran B, Fulton-Lieuw T, Dalby M, Mistry P, Sen M, O'Toole L, Al Booz H, Dyker K, Moleron R, Whitaker S, Brennan S, Cook A, Griffin M, Aynsley E, Rolles M, De Winton E, Chan A, Srinivasan D, Nixon I, Grumett J, Leemans CR, Buter J, Henderson J, Harrington K, McConkey C, Gray A, Dunn J; De-ESCALaTE HPV Trial Group. Mehanna H, et al. Among authors: sen m. Lancet. 2019 Jan 5;393(10166):51-60. doi: 10.1016/S0140-6736(18)32752-1. Epub 2018 Nov 15. Lancet. 2019. PMID: 30449623 Free PMC article. Clinical Trial.
Chemotherapy and Targeted Therapy.
Sen M, Prestwich R. Sen M, et al. Adv Otorhinolaryngol. 2016;78:148-56. doi: 10.1159/000442135. Epub 2016 Apr 12. Adv Otorhinolaryngol. 2016. PMID: 27093440 Review.
Neutralizing Aptamers Block S/RBD-ACE2 Interactions and Prevent Host Cell Infection.
Liu X, Wang YL, Wu J, Qi J, Zeng Z, Wan Q, Chen Z, Manandhar P, Cavener VS, Boyle NR, Fu X, Salazar E, Kuchipudi SV, Kapur V, Zhang X, Umetani M, Sen M, Willson RC, Chen SH, Zu Y. Liu X, et al. Among authors: sen m. Angew Chem Weinheim Bergstr Ger. 2021 Apr 26;133(18):10361-10366. doi: 10.1002/ange.202100345. Epub 2021 Mar 22. Angew Chem Weinheim Bergstr Ger. 2021. PMID: 34230707 Free PMC article.
Neutralizing Aptamers Block S/RBD-ACE2 Interactions and Prevent Host Cell Infection.
Liu X, Wang YL, Wu J, Qi J, Zeng Z, Wan Q, Chen Z, Manandhar P, Cavener VS, Boyle NR, Fu X, Salazar E, Kuchipudi SV, Kapur V, Zhang X, Umetani M, Sen M, Willson RC, Chen SH, Zu Y. Liu X, et al. Among authors: sen m. Angew Chem Int Ed Engl. 2021 Apr 26;60(18):10273-10278. doi: 10.1002/anie.202100345. Epub 2021 Mar 22. Angew Chem Int Ed Engl. 2021. PMID: 33684258 Free PMC article.
Management of Advanced Head and Neck Cancer.
Prestwich RJ, Sen M, Scarsbrook AF. Prestwich RJ, et al. Among authors: sen m. N Engl J Med. 2016 Aug 4;375(5):491-2. doi: 10.1056/NEJMc1606211. N Engl J Med. 2016. PMID: 27518681 Free article. No abstract available.
Randomized Phase 3 Trial of the Hypoxia Modifier Nimorazole Added to Radiation Therapy With Benefit Assessed in Hypoxic Head and Neck Cancers Determined Using a Gene Signature (NIMRAD).
Thomson DJ, Slevin NJ, Baines H, Betts G, Bolton S, Evans M, Garcez K, Irlam J, Lee L, Melillo N, Mistry H, More E, Nutting C, Price JM, Schipani S, Sen M, Yang H, West CM; NIMRAD Trial Group. Thomson DJ, et al. Among authors: sen m. Int J Radiat Oncol Biol Phys. 2023 Dec 9:S0360-3016(23)08184-1. doi: 10.1016/j.ijrobp.2023.11.055. Online ahead of print. Int J Radiat Oncol Biol Phys. 2023. PMID: 38072326 Free article.
CompARE: study protocol for a phase III randomised controlled platform trial comparing alternative regimens for escalating treatment of intermediate and high-risk oropharyngeal cancer.
Mehanna H, Gaunt P, Kong A, Hartley A, Sanghera P, Forster M, Sen M, Paleri V, Fong C, Geropantas D, Srinivasan D, Garikipati S, Moleron R, Casswell G, Aynsley E, Ward A, O'Toole L, Mirza A, Firth C, Humphreys I, Fulton-Lieuw T, Roques T, Nankivell P. Mehanna H, et al. Among authors: sen m. Trials. 2024 Jan 15;25(1):50. doi: 10.1186/s13063-023-07881-1. Trials. 2024. PMID: 38221636 Free PMC article.
73 results